Related Experiment Videos
Activation of cytotoxic T cells by solid tumours?
1Ludwig Institute for Cancer Research, Centre Hospitalier Universitaire de Lausanne, Switzerland.
Cellular and Molecular Life Sciences : CMLS
|May 12, 1998
Summary
Tumour-specific cytotoxic T cells (CTLs) fail to control cancer because tumours, like normal tissues, cannot effectively activate immune responses. Antigens don't reach lymph nodes, hindering CTL activation for better cancer immunity.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Cytotoxic T cells (CTLs) are key biological weapons against cancer.
- However, CTLs often fail to eliminate tumors in vivo.
- Tumor immune evasion is often attributed to active tumor mechanisms.
Purpose of the Study:
- To challenge the notion of active tumor immune evasion.
- To propose that intrinsic tumor properties limit immune response activation.
- To explain why tumors fail to induce effective anti-tumor immunity.
Main Methods:
- Review of existing literature on tumor immunology and CTL function.
- Analysis of immune mechanisms in solid tumors versus normal tissues.
- Evaluation of antigen presentation and localization in lymphoid tissues.
Main Results:
- Many "immune escape" mechanisms are shared by tumors and normal tissues.
- Tumor antigens poorly localize to lymph follicles, impairing CTL priming.
- Tumors lack efficient antigen presentation in an immunogenic context.
Conclusions:
- Tumor-induced immune failure stems from an intrinsic inability to activate T cells.
- This inability is similar to that of normal tissues, not a specific tumor adaptation.
- Enhanced immunization protocols could improve clinical outcomes by overcoming poor CTL induction.